title: Rectovaginal fistula.
abstract: Despite the prevalence and severe implications of rectovaginal fistula, there is no universally accepted evidence-based approach to surgical management. This article offers a disease-based review of traditional management strategies and highlights the variety of technical approaches that are currently effective for the eradication of this socially disabling condition.
authors.affiliation: Division of Colorectal Surgery, University Hospitals Case Medical Center, Case Western Reserve University, 11100 Euclid Avenue, Cleveland, OH 44106-5047, USA. brad.champagne@uhhospitals.org
authors.forename: Bradley J
authors.initials: BJ
authors.lastname: Champagne
authors.forename: Michael F
authors.initials: MF
authors.lastname: McGee
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003424:Crohn Disease / Q000150:complications; D005260:Female; D005833:Genital Neoplasms, Female / Q000150:complications; D006801:Humans; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D010808:Physical Examination; D011878:Radiotherapy / Q000009:adverse effects; D012004:Rectal Neoplasms / Q000150:complications; D012006:Rectovaginal Fistula / Q000175:diagnosis / Q000209:etiology / Q000601:surgery*
chemical_list: D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab